Here’s what you should know. 1. EMcision is a privately held company in the U.K. and Canada that created the Habib EndoHPB probe, a novel endoscopic bipolar radiofrequency device. The probe helps ...
After acquiring LumenR and EndoChoice, Boston Scientific committed to leaning on its endoscopy business to drive growth company-wide, Trefis reports. Here’s what you need to know. 1. In addition to ...
Zacks Investment Research on MSN
M&A Strategy Strengthens Boston Scientific's Growth Prospects
Over the past several years, Boston Scientific BSX has pursued a series of acquisitions in support of its growth strategy, both strengthening its core businesses and expanding into high-growth ...
Boston Scientific will expand its portfolio of products treating gastrointestinal conditions by purchasing EndoChoice Holdings Inc. for $210 million, the company said Tuesday. Boston Scientific—which ...
On September 30, 2025, Boston Scientific Corporation presented at MEDevice Boston, featuring insights from Ann Roy, Vice President of Health Economics and Market Access, and Liza Davis, Vice President ...
Boston Scientific has again updated the instructions for use (IFU) and use recommendations connected to its Q124 correction of the Obsidio Conformable Embolic after reporting two additional deaths and ...
Boston Scientific BSX is gaining market share across all segments. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2 (Buy) currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback